Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond

Anaplastic Lymphoma Kinase (ALK)-positive Anaplastic Large Cell Lymphoma (ALCL), remains one of the most curable cancers in the paediatric setting; multi-agent chemotherapy cures approximately 65–90% of patients. Over the last two decades, major efforts have focused on improving the survival rate by...

Descripción completa

Detalles Bibliográficos
Autores principales: Prokoph, Nina, Larose, Hugo, Lim, Megan S., Burke, G. A. Amos, Turner, Suzanne D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923354/
https://www.ncbi.nlm.nih.gov/pubmed/29601554
http://dx.doi.org/10.3390/cancers10040099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923354/
https://www.ncbi.nlm.nih.gov/pubmed/29601554
http://dx.doi.org/10.3390/cancers10040099

Ejemplares similares